Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Inevitably fatal some 40 years, acute promyelocytic leukemia (APL) can now be cured in more than 95% of cases. This clinical success story is tightly linked to tremendous progress in our understanding of retinoic acid (RA) signaling. The discovery of retinoic acid receptor alpha (RARA) was followed by the cloning of the chromosomal translocations driving APL, all of which involve RARA. Since then, new findings on the biology of nuclear receptors have progressively enlightened the basis for the clinical efficacy of RA in APL. Reciprocally, the disease offered a range of angles to approach the cellular and molecular mechanisms of RA action. This virtuous circle contributed to make APL one of the best‐understood cancers from both clinical and biological standpoints. Yet, some important questions remain unanswered including how lessons learnt from RA‐triggered APL cure can help design new therapies for other malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889 · cited 1×
“RARs are members of the super-family of nuclear hormone receptors, which directly regulate the transcription of their target genes in the nucleus.(12,13) These receptors bind DNA on specific sequences called hormone-responsive elements (HREs) and display activating or repressive transcriptional properties depending on…”
BackgroundThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 1×
“17) that releases corepressors and allows the recruitment of coactivators which open chromatin and attract the transcription machinery, resulting in the transactivation of target genes.(18) Importantly, liganddependent activation also elicits RARA catabolism through the ubiquitin/proteasome pathway.”
BackgroundA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
Breitman, T. R., Selonick, S. E., & Collins, S. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2936 · Cited by 1,966 · cited 1×
“Notably, blasts from a subtype of acute myeloid leukemias (AMLs) called acute promyelocytic leukemia (APL) undergo terminal maturation into granulocytes upon ex vivo treatment.(3,4) Starting in the mid-1980s, the use of RA to treat the patients with APL led to dramatic improvements in remission and survival rates.”
BackgroundIdentification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965 · cited 2×
“The identification of receptors for RA in 1987 initiated a considerable expansion of the field toward the molecular understanding of RA signaling.(8,9) The subsequent realization that aberrant RA signaling could be implicated in the pathogenesis of APL (Ref.”
BackgroundRetinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Retinoic Acid Synthesis and Signaling during Early Organogenesis
Duester, G. (2008) · Cell · doi:10.1016/j.cell.2008.09.002 · Cited by 1,098
Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2456 · Cited by 706
Schenk, T., Chen, W. C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.-U., Popescu, A. C., Burnett, A., Mills, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2661 · Cited by 672 · cited 1×
“Similarly, inhibition of the lysine demethylase LSD1, which is overexpressed in AML, was shown to cause an epigenetic reprogramming that enables RA to differentiate a non-APL, AML cell line.(145) This effect was associated with decreased engraftment capacity of human AML samples into immunodeficient mice, suggesting t…”
BackgroundRetinoids, Retinoic Acid Receptors, and Cancer
Tang, X.-H., & Gudas, L. J. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130303 · Cited by 596 · cited 1×
“Alterations of RA Signaling in Cancer Several players in the RA pathway were shown to be altered in cancer, suggesting that defective RA signaling may contribute to oncogenesis.(32) First, enzymes modulating vitamin A uptake, such as lecithin:retinol acyltransferase, and availability, such as cellular retinol binding…”
BackgroundVitamin A and retinoid signaling: genomic and nongenomic effects
Al Tanoury, Z., Piskunov, A., & Rochette-Egly, C. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r030833 · Cited by 408
Function of retinoic acid receptors during embryonic development
Mark, M., Ghyselinck, N. B., & Chambon, P. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07002 · Cited by 363 · cited 1×
“RARs have thus been shown to control a large number of developmental processes.(29) Yet, mice lacking only one RAR generally display few tissue-restricted abnormalities, indicating a degree of functional redundancy between RARs.”
BackgroundRetinoic Acid Signaling Is Essential for Embryonic Hematopoietic Stem Cell Development
Chanda, B., Ditadi, A., Iscove, N. N., & Keller, G. (2013) · Cell · doi:10.1016/j.cell.2013.08.055 · Cited by 201 · cited 1×
“Interestingly, RA has been recently reported to directly govern hematopoietic stem cell (HSC) production from the hemogenic endothelium by transiently blocking WNT signaling.(27) At later stages, maintenance of HSC self-renewal in the bone marrow niche seems to require the constant inactivation of extracellular RA by…”
BackgroundKopf, E., Plassat, J.-L., Vivat, V., de Thé, H., Chambon, P., & Rochette-Egly, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002840200 · Cited by 155 · cited 1×
“Importantly, liganddependent activation also elicits RARA catabolism through the ubiquitin/proteasome pathway.(19,20) This negative feedback mechanism is compensated by the autoregulation of RARA expression via the presence of RAREs in the promoter sequence of the RARA gene,(21) permitting the precise control of RARA…”
BackgroundEstey, E. H., Giles, F. J., Kantarjian, H., O’Brien, S., Cortes, J., Freireich, E. J., Lopez-Berestein, G., & Keating, M. (1999) · Blood · doi:10.1182/blood.v94.7.2230.419k05_2230_2235 · Cited by 105 · cited 1×
“Although the standard RA regimen appears unable to cure APL patients as a monotherapy, treatment using liposomes for RA delivery, which sustain much higher intracellular concentrations, yielded a significant proportion of definitive cures.(71,76) Interestingly, this very tight dose dependence mirrors the two-step mole…”
BackgroundThe Drug-Induced Degradation of Oncoproteins: An Unexpected Achilles' Heel of Cancer Cells?
Ablain, J., Nasr, R., Bazarbachi, A., & de Thé, H. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0087 · Cited by 44
Self-citationZhu, L., Santos, N. C., & Kim, K. H. (2009) · Endocrinology · doi:10.1210/en.2009-0868 · Cited by 32 · cited 1×
“In addition, RARA can undergo several post-translational modifications, including serine and threonine phosphorylation and lysine sumoylation, which finely tune its structural conformation and therefore modulate its stability and/or activity.(22,23) Figure 1.”
Background
Cited by
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Day, C.-P., Merlino, G., & Van Dyke, T. (2015) · Cell · doi:10.1016/j.cell.2015.08.068 · Cited by 676
Hatterschide, J., Bohidar, A. E., Grace, M., Nulton, T. J., Kim, H. W., Windle, B., Morgan, I. M., Munger, K., & White, E. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819534116 · Cited by 112
Cortes, E., Lachowski, D., Rice, A., Chronopoulos, A., Robinson, B., Thorpe, S., Lee, D. A., Possamai, L. A., Wang, H., Pinato, D. J., et al. (2019) · Hepatology · doi:10.1002/hep.30193 · Cited by 64
Hatterschide, J., Brantly, A. C., Grace, M., Munger, K., & White, E. A. (2020) · Journal of Virology · doi:10.1128/jvi.01024-20 · Cited by 33
Metadata
- Authors
- Ablain, J., & de Thé, H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-08-14
- Volume
- 135
- Issue
- 10
- Pages
- 2262-2272
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2121650311
- Cited by
- 76
- References
- 19
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.